The Recall Desk
SevereFDA (Food)·F-2400-2014·Announced 2014-09-03

Beta Labs Recalls PHEnFX Dietary Supplement Containing Unapproved DMAA

Beta Labs is recalling 743 units of PHEnFX dietary supplements because they contain DMAA, a substance not permitted in dietary supplements.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving unapproved substances in dietary supplements.

Plain-English summary

Beta Labs, LTD is recalling 743 units of PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES. The product was distributed nationwide and in the UK. The specific lot number is 1205129 with an expiration date of 12/16.

The recall is being conducted because the products contain DMAA (1,3-dimethylamylamine), also known as methylhexamine or geranium extract. The U.S. Food and Drug Administration states that DMAA is not permitted in dietary supplements.

Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund or contact the recalling firm for further instructions.

The recalled product

Product
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
Manufacturer
Beta Labs
Affected units
743

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 1205129
  • Exp 12/16

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 4 recalled by Beta Labs under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →